Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jun;43(6):e25.
doi: 10.1136/jmg.2005.034397.

CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea

CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea

A Oshima et al. J Med Genet. 2006 Jun.

Abstract

Background: In a search for mutations of mu-crystallin (CRYM), a taxion specific crystalline which is also known as an NADP regulated thyroid hormone binding protein, two mutations were found at the C-terminus in patients with non-syndromic deafness.

Objective: To investigate the mechanism of hearing loss caused by CRYM mutations

Methods: T3 binding activity of mutant mu-crystallin was compared with that of wild-type mu-crystallin, because mu-crystallin is known to be identical to T3 binding protein. To explore the sites within the cochlea where mu-crystallin is functioning, its localisation in the mouse cochlea was investigated immunocytochemically using a specific antibody.

Results: One mutant was shown to have no binding capacity for T3, indicating that CRYM mutations cause auditory dysfunction through thyroid hormone binding properties. Immunocytochemical results indicated that mu-crystallin was distributed within type II fibrocytes of the lateral wall, which are known to contain Na,K-ATPase.

Conclusions: CRYM mutations may cause auditory dysfunction through thyroid hormone binding effects on the fibrocytes of the cochlea. mu-Crystallin may be involved in the potassium ion recycling system together with Na,K-ATPase. Future animal experiments will be necessary to confirm a causal relation between Na,K-ATPase, T3, and deafness.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared

References

    1. Abe S, Katagiri T, Saito‐Hisaminato A, Usami S, Inoue Y, Tsunoda T, Nakamura Y. Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am J Hum Genet 20037273–82. - PMC - PubMed
    1. Kim R Y, Gasser R, Wistow G J. Mu‐crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc Natl Acad Sci USA 1992899292–9296. - PMC - PubMed
    1. Vie M P, Evrard C, Osty J, Breton‐Gilet A, Blanchet P, Pomerance M, Rouget P, Francon J, Blondeau J P. Purification, molecular cloning, and functional expression of the human nicodinamide‐adenine dinucleotide phosphate‐regulated thyroid hormone‐binding protein. Mol Endocrinol 1997111728–1736. - PubMed
    1. Kobayashi M, Hashizume K, Suzuki S, Ichikawa K, Takeda T. A novel NADPH‐ dependent cytosolic 3,5,3′‐triiodo‐L‐thyronine (T3)‐binding protein (CTBP; 5.1S) in rat liver. A comparison with 4.7SNADPH‐ dependent CTBP. Endocrinology 19911291701–1708. - PubMed
    1. Hashizume K, Suzuki S, Ichikawa K, Takeda T. Purification of cytosolic 3,5,3′‐ triiodo‐L‐thyronine(T3)‐binding protein(CTBP), which regulates nuclear T3 translocation. Biochem Biophys Res Commun 19911741084–1089. - PubMed

Publication types

MeSH terms